Forbes January 12, 2021
Seth Joseph

GoodRx qualified as a unicorn prior to its IPO, but its story and ambition is rare enough that it may warrant a new mythological creature dedication. Founded in 2011, the nine year-old digital health company went public last September with $388 million in 2019 revenue and, more surprisingly, $139 million in operating profit.

GoodRx is best known for making prescription drug pricing transparent and offering discount coupons to consumers, allowing consumers to shop for which pharmacy provides the best combination of price and convenience. The company earns revenue only only when it saves people money. Thus far, the company estimates it has helped Americans realize $20 billion in savings.

Doing good is going well for GoodRx and its...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Insurance, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology
Funding Flows to Value-Based Care, Defib Tech, Analytics, and More | StartUp Health Insights: Week of Apr 23, 2024
Ozempic And Other Weight Loss Drugs Will Only Work With Digital Health
‘Investors Are Hungry To Find the Best’: It’s Feast or Famine in Digital Behavioral Health Investing
Delivering the Right Approach for Virtual Primary Care: 3 Key Insights
Q&A: Bring your own device: How patients own tech is being used in clinical trials

Share This Article